Urodynamix Technologies Ltd.

Urodynamix Technologies Ltd.

Urodynamix Technologies takes a delicate approach to monitoring urological problems. The company develops and commercializes medical imaging products used in screening, diagnosing, and treating urology-centered conditions. The company's technology is based on near-infrared spectroscopy (NIRS) and is being applied to non-invasive monitoring of urinary incontinence, prostate cancer, and other urological and vascular ailments. It's bladder monitoring system has received FDA approval in the US and a CE mark in the EU. Urodynamix partners with other companies to distribute its products. Chinese pharmaceutical firm HEGLN intends to acquire the assets of Urodynamix.

Contact Details

Office Address

Urodynamix Technologies Ltd.
Suite 1485, Bentall Centre Two, 555 Burrard Street, Box 213
Vancouver, British Columbia, Canada V7X1M9
Phone: (604) 694-7770
Fax: (604) 694-7771

Executives

Chairman, President, and CEO

Barry J. Allen

CFO

Jonathan Jackson

Business Reviews for Urodynamix Technologies Ltd.

Related Companies